arrow Log In to View Account     |      
Johns Hopkins Medicine
Hopkins Logo


Click below to register.

Saturday, December 8, 2018
JW Marriott Houston

5150 Westheimer Rd
Houston, TX
Room: TBD

7:30 AM – 8:00 AM: Registration and Breakfast
8:00 AM – 12:30 PM: Interactive CME/CNE Activity

Multiple sclerosis (MS) is a highly heterogeneous disease with regard to presenting symptoms, disease activity, relapse, and rate of disability progression. Although there is no cure for MS, a plethora of diverse current and emerging disease modifying therapies aim to slow disease progression, reduce relapses, and limit disability. However, clinical uncertainties create questions regarding the diagnosis, treatment, and overall management of patients with MS. These questions include: How do we recognize symptoms and accurately diagnose MS? Which therapies should be used? When is the best time to initiate, switch, and/or discontinue treatment? How do we incorporate continuously emerging real-world data into treatment decision-making? How do we optimally manage symptoms while minimizing treatment side effects and improve patient’s health-related quality of life? How do we facilitate shared decision-making and patient-centered care?

This interactive live symposium series will bring together MS experts to present and discuss the latest criteria and methodologies involved in MS diagnosis, to evaluate the most recent clinical trial and real-world data on MS treatment strategies, and to optimize patient-center management to improve outcomes for patients with MS. This program will include breakout sessions to discuss case studies from the perspectives of the neurologist, the MS specialty nurse, and the primary care provider.

The goal of this program is to provide neurologists, primary care physicians, nurse practitioners, physician assistants, nurses and other healthcare providers who treat patients with MS with the latest science and clinical issues related to the management of MS as well as the opportunity to discuss cases with local MS experts.

This initiative is intended for neurologists, primary care physicians, nurse practitioners, physician assistants, nurses, and other healthcare providers who treat patients with MS. No prerequisites required.

After attending this activity, participants will demonstrate the ability to:
  • IDENTIFY key factors necessary for the differential diagnosis of MS.
  • EVALUATE the most recent clinical data on approved DMTs for MS.
  • ASSESS investigational DMTs for MS, including relapsing and progressive MS.
  • RECOGNIZE the role of patient preferences and disease-specific factors that inform treatment decision-making.
  • IMPLEMENT interprofessional strategies, incorporating shared decision-making, to individualize MS management plans.
The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing take responsibility for the content, quality, and scientific integrity of this CME/CNE activity.

accme_logoThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and, The Institute for Johns Hopkins Nursing, The Consortium of Multiple Sclerosis Centers, and The International Organization of MS Nurses. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This 4.0 contact hour educational activity is provided by the Institute for Johns Hopkins Nursing. Claim only those contact hours actually spent in the activity.

7:30 – 8:00 AM Registration and Breakfast
8:00 – 8:15 AM Conference Goals and Pre-assessment
8:15 – 8:55 AM Update on Multiple Sclerosis: Overview and Diagnosis – Red Flags for Misdiagnosis of MS
8:55 – 9:35 AM Remaining Up-to-Date with the Evolving DMT Landscape in MS
9:35 – 10:15 AM Symptom Management and Interprofessional Strategies to Individualize Treatment
10:15 – 10:30 AM Break
10:30 – 12:15 PM Breakout Sessions
Track 1: Neurologists/Specialty Nurses’ Perspectives
Track 2: Primary Care Provider Perspectives
12:15 – 12:30 PM Activity Conclusion and Post-assessment

This schedule is subject to change.

Scott Newsome, DO, MSCS, FAAN
Associate Professor of Neurology
Johns Hopkins University School of Medicine
Director, Neurosciences Consultation and
Infusion Center at Green Spring Station
Director, Stiff Person Syndrome Center
Member, Miller-Coulson Academy of Clinical Excellence
Johns Hopkins Hospital
Division of Neuroimmunology and Neuroinfectious Diseases
Baltimore, Maryland

Lisa Fox, PA-C, MS
Johns Hopkins Hospital
Physicians’ Assistant, Department of Neurology
Division of Neuroimmunology and Neuroinfectious Diseases
Baltimore, Maryland
Kathleen Costello, MS, ANP-BC, MSCN
Nurse Practitioner
Johns Hopkins Multiple Sclerosis Center
Associate Vice President Healthcare Access
National MS Society
Baltimore, Maryland

George J. Hutton, MD
Professor of Neurology
Linda and John Griffin Endowed Chair in Multiple Sclerosis
Vice Chair for Clinical Affairs
Medical Director
Maxine Mesinger Multiple Sclerosis Comprehensive Care Center
Department of Neurology
Baylor College of Medicine
Houston, Texas
Derrick Robertson, MD
Associate Professor, Department of Neurology
Director, Multiple Sclerosis Division
University of South Florida, Morsani College of Medicine
Tampa, Florida

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

It is the policy of the Institute for Johns Hopkins Nursing to require our continuing nursing education program faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the program. Detailed disclosures will be made in the course materials.

The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

There is no fee for this educational activity.

<img src="" alt="procced to pretest" border="0" />

Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334), is published by ASiM CE, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2017 by ASiM CE, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of ASiM CE LLC.